COMMUNIQUÉS West-GlobeNewswire

World Stroke Organization and Philips call for action to expand access to life-saving stroke care

10/09/2024 - 15:00

September 10, 2024 Joint policy paper provides recommendations for effective policymaking and investments in stroke centers with specialized treatments to improve health outcomes and reduce costs Timely access to [...]

Visory Health Supports Local Families with Nourishing Meal in Collaboration with Ronald McDonald House Charities® of St. Louis’s Meals from the Heart Program

10/09/2024 - 15:00

Nearly 50 St. Louis Ronald McDonald House residents ate a delicious meal with the Visory Health team, learning about affordable healthcare resources available to them ST. LOUIS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Visory [...]

Abvance Therapeutics Announces $3.9M Program Related Investment from the Helmsley Charitable Trust to Support Development of Its Novel Insulin and Glucagon Combined Formulation

10/09/2024 - 15:00

Abvance is developing ABV100, a proprietary, clinically validated combination of insulin and glucagon with a goal of improving glycemic control while reducing hypoglycemia for people with diabetes who require rapid [...]

Alopexx Announces Collaboration with Bharat Biotech for the Development and Commercialization of Broad-Spectrum Anti-Microbial Vaccine AV0328

10/09/2024 - 15:00

Strategic Collaboration Aims to Accelerate Global Access to Potentially Life-Saving Vaccine Cambridge, MA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Alopexx, Inc., a clinical-stage biotechnology company focused on developing [...]

OneMedNet appoints new CFO

10/09/2024 - 14:45

MINNEAPOLIS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), has announced that Bob Golden has [...]

SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board

10/09/2024 - 14:30

Dr. Moll, founder of Intuitive Surgical, to serve as Vice Chairman FORT LAUDERDALE, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a [...]

Corvus Pharmaceuticals Initiates Registrational Phase 3 Clinical Trial of Soquelitinib for Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma

10/09/2024 - 14:30

Soquelitinib is a potential first-in-class ITK inhibitor with broad potential in cancer and immune diseases There are currently no fully approved agents for the treatment of relapsed PTCL and soquelitinib has been [...]

Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research

10/09/2024 - 14:30

A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and treatment of spinal cord injuries as a practicing Physician, Professor, and Research [...]

Danam Health, Inc. Announces Acquisition of Wellgistics, LLC

10/09/2024 - 14:05

Tampa, FL, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Danam Health, Inc. (“Danam”) today announced that it completed its acquisition of Wellgistics, LLC (“Wellgistics”). Acquisition of Wellgistics, LLC Danam Health is excited [...]

Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals

10/09/2024 - 14:00

BURLINGTON, Mass. and JERUSALEM, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments [...]

New Secondary Analysis of Phase 3 Data Demonstrates Sotagliflozin Improves Time-In-Range (TIR) and Several Parameters of Glucose Control and Variability in Basal Insulin-Treated Type 2 Diabetes

10/09/2024 - 14:00

Study results aligned with positive clinical trial outcomes for type 1 diabetes treatment with sotagliflozin TIR measures approach target set by American Diabetes Association Data to be presented at the 60th Annual [...]

Study Suggests Non-invasive Vagus Nerve Stimulation (nVNS) is effective in accelerating United States Air Force Pilot Training

10/09/2024 - 14:00

Clinical trial demonstrates the ability of nVNS to accelerate sensorimotor learning in USAF Simulator Based Pilot Training ROCKAWAY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a [...]

American Burn Association Study Highlights Inequities in Access to Specialized Burn Care

10/09/2024 - 14:00

Spectral AI’s DeepView® System Designed to Provide Equity in Burn Care Access While Optimizing Healthcare Resources DALLAS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “ [...]

A new report from the Access to Medicine Foundation reveals how patient-focused pharma companies' access efforts are

10/09/2024 - 14:00

AMSTERDAM, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The latest report from the Access to Medicine Foundation takes a first-ever look at the critical issue of how some of the largest pharmaceutical companies are reaching [...]

Un nouveau rapport de l’Access to Medicine Foundation révèle à quel point les efforts des entreprises pharmaceutiques en matière d’accès aux médicaments sont axés sur les patients

10/09/2024 - 14:00

AMSTERDAM, 10 sept. 2024 (GLOBE NEWSWIRE) -- Le dernier rapport de l’Access to Medicine Foundation se penche pour la première fois sur la question cruciale de l’approche de certaines des plus grandes entreprises [...]

Vaping Expected to Increase COPD Health and Economic Burden by 2050

10/09/2024 - 14:00

New ResMed-supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in Western Europe, accounting for increased air pollution, tobacco smoking, and vaping, with Non- [...]

Connect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024

10/09/2024 - 14:00

SAN DIEGO, CA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma,” “Connect” or the “Company”), a U.S.-headquartered global clinical-stage biopharmaceutical company [...]

Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference

10/09/2024 - 14:00

CARLSBAD, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management [...]

Korro to Participate in Upcoming Investor Conferences

10/09/2024 - 14:00

CAMBRIDGE, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and [...]